1. South Korea Stocks

  2. •

    Producer manufacturing

  3. •

    Industrial machinery
HLB innoVation Co., Ltd.

HLB innoVation Co., Ltd.

KKRX:024850
15,920.00
KRW
+40.00
(+0.25%)
-1,196.12EPS
648.71BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
10,609.66
6,511.42
5,305.33
1,362.23
6,265.74
5,575.36
4,526.81
4,784.32
6,261.37
3,748.51
1,498.49
1,481.63
1,126.49
1,179.31
Basic EPS, GAAP
-610
-1,530
-425
-230
75
-110
30
-475
-104.12
1,665
-55
-720
-1,165
-1,183.51
Free Cash Flow per Basic Share
-83.07
-1,537.62
-312.33
-49.65
-96.35
-203.69
165.46
117.85
64.41
-192.5
73.59
-1,613.98
-1,081.68
-1,040.21
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
4,587.45
3,183.97
2,874.83
2,513.73
2,542.07
2,451.53
2,413.75
1,867.22
1,848.42
4,318.18
4,290.37
8,506.75
6,984.74
7,366.88
Tangible Book Value per Share
4,587.45
3,183.97
2,874.83
2,513.73
2,542.07
2,451.53
2,413.75
1,867.22
1,848.42
4,314.04
4,286.86
2,128.03
1,040.26
1,098.97
Basic Weighted Avg Shares
8
8
8
8
8
8
8
8
8
8
14
17
29
29
Sales/Revenue/Turnover
80,554
50,009
40,855
10,617
50,020
43,799
38,027
38,320
50,747
31,429
20,581
25,356
32,264
34,161
Operating Margin (%)
-2.86
-17.59
-20.99
-10.6
2.2
-4.55
-1.98
-7.12
1.67
1.28
-4.56
-46.86
-116.39
-111.55
Depreciation Expense
3,853
2,916
2,830
536
1,942
1,599
1,977
2,035
1,865
1,209
977
1,234
2,100
2,135
Net Income, GAAP
-4,631
-11,751
-3,273
-1,793
599
-864
252
-3,805
-844
13,960
-755
-12,322
-33,367
-34,282
Effective Tax Rate (%)
- -
- -
- -
- -
17.5
- -
9.91
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-5.75
-23.5
-8.01
-16.88
1.2
-1.97
0.66
-9.93
-1.66
44.42
-3.67
-48.6
-103.42
-100.36
Working Capital
15,483
10,277
9,481
8,042
9,695
10,492
12,759
10,004
12,941
80,008
28,861
41,963
1,162
5,573
LT Debt
- -
1,000
1,000
1,000
875
625
389
2,874
4,970
30,633
2,078
2,474
1,259
981
Total Equity
34,700
24,656
22,262
19,466
19,685
18,984
19,315
14,941
14,997
57,432
57,062
251,983
221,320
234,416
Return on Invested Capital (%)
- -
- -
- -
- -
3.65
- -
-2.75
- -
- -
0.68
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
3.09
- -
1.91
- -
- -
24.21
- -
- -
- -
- -
Return on Common Equity (%)
-12.58
-39.59
-13.95
-8.59
3.06
-4.47
1.32
-22.21
-5.64
38.55
-1.32
-8.14
-14.63
-15.01

Capital Structure

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
34,486
34,972
23,474
LT Borrowings
- -
- -
- -
LT Finance Leases
1,470
1,259
981
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
29
30
30
Market Capitalization
262,398
300,620
648,706

Working Capital

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
53,310
47,332
42,390
Cash, Cash Equivalents & STI
40,260
31,840
25,034
Accounts Receivable, Net
4,121
4,965
5,681
Inventories
7,957
8,603
9,546
Total Current Liabilities
44,582
46,170
36,816
Payables & Accruals
- -
- -
- -
ST Debt
34,486
34,972
23,474
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
57.62%
122.42%
-12.17%
Free Cash Flow
-353.31%
-687.4%
12.16%
Net Income, GAAP
-239.74%
-47.12%
170.8%
Sales/Revenue/Turnover
28.25%
2.06%
27.24%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
6,133
6,202
5,761
- -
25,356
2025
7,550
8,990
7,564
8,161
32,264
2026
9,446
- -
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2
-3.18
-22
- -
-720
2025
-324.59
-345.45
-335.4
-152.03
-1,165
2026
-350
- -
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
Full Time Employees
61
Sector
Producer manufacturing
Industry
Industrial machinery
Address
Hwaseong-si South Korea
IPO Date
Jan 18, 2001
Website
hlbinnovation.com
Similar Companies
Applied Materials, Inc. (NASDAQ:AMAT)
Oklo Inc. (NYSE:OKLO)
Lam Research Corporation (NASDAQ:LRCX)
Tokyo Electron Ltd. (TSE:8035)
Welspun Corp Limited (NSE:WELCORP)
Symbotic Inc. (NASDAQ:SYM)
Business
HLB innoVation Co., Ltd. is a South Korea-based technology and biotechnology company primarily engaged in the manufacturing of semiconductor lead frames and the research and clinical development of cell-based immunotherapies. The company operates through two principal business segments: Semiconductor Materials and Bio/Therapeutics. Its product and service offerings comprise etched and stamped lead frames for integrated circuits (ICs); discrete semiconductor and power transistor lead frames; automotive semiconductor frames; light-emitting diode (LED) lead frames; high-precision electronic connectors and stamping mold dies; and next-generation chimeric antigen receptor T-cell (CAR-T) immuno-oncology drug development assets utilizing the multi-chain SynKIR platform, featuring clinical candidate SynKIR-110 targeted at mesothelin-expressing solid tumors such as mesothelioma, ovarian cancer, and cholangiocarcinoma, as well as candidate SynKIR-310 for hematological malignancies. The company supplies semiconductor assembly and test service providers, automotive electronics suppliers, and electronic device manufacturers across South Korea, greater Asia, North America, and Europe. Founded in 1978 and headquartered in Hwaseong-si, Gyeonggi-do, South Korea, the company operates manufacturing facilities in South Korea and biopharmaceutical research operations in the United States as a member of the HLB Group. Formerly known as PSMC Co., Ltd., the company changed its name to HLB innoVation Co., Ltd. in March 2023 following its acquisition by the HLB Group. In recent strategic developments, the company diversified into biotechnology through the acquisition and integration of United States-based cell therapy specialist Verismo Therapeutics, Inc., established a dedicated bio division to advance clinical trials for CAR-T solid tumor therapies, and reorganized its capital structure to support both expanded lead frame manufacturing capacity for automotive power semiconductors and advanced oncology pipeline development.